physiologically based pharmacokinetic (PBPK) models to estimate virtually safe environmental concentra-the Appendix). While currently inconclusive, such data tions for humans based on rodent cancer-bioassay are the basis for current regulatory interest in methods data. We show here how such methods can be extended to define safe levels of TCE exposure for cancer end to the case in which TCE is assumed to induce cancer points under a cytotoxic mechanism-of-action assumpvia cytotoxicity, to estimate environmentally safe con-tion, even if only for comparison with levels defined centrations based on rodent toxicity data. These meth-by default linear risk extrapolation based on assumed ods can be substituted for the numerical methods typi-genotoxic mechanisms (EPA, 1996). In this paper, we cally used to calculate PBPK-effective doses when show how algebraic methods can be used to calculate these are defined as peak concentrations. We selected maximum concentration levels (MCLs) for hypothetical liver and kidney as plausible target tissues, based on TCE-induced cancer in humans from data on the no an analysis of rodent TCE-bioassay data and on a re-observed adverse effect level (NOAEL) for related cytoview of related data bearing on mechanism. Tumor toxic end points in experimental animals. patterns in rodent bioassays are shown to be consisPrevious PBPK-based risk estimates for TCE have tent with our estimates of PBPK-based, effective cyto-used cumulative or average dose measures, such as toxic doses to mice and rats used in these studies. average mg TCE metabolized/day/kg body weight, or When used with a margin of exposure of 1000, our area under a curve reflecting metabolite concentration method yielded maximum concentration levels for vs time (EPA, 1985(EPA, , 1987 Bogen, 1988 
volatile organic compounds like TCE (Bogen and taking into account life table data available for bioassays conducted by the National Cancer Institute (NCI) McKone, 1987; Bogen, 1988; Bogen and Hall, 1989) . However, these integral measures are appropriate only and the National Toxicology Program (NTP) (Peto et al., 1984) . With many experiments, some P values may if the toxic mechanism involves an accumulation of critical (e.g., DNA) damage over time. Rodent-bioassay and be small just by chance. Therefore, Table 1 also reports an overall P value for each target site, using Fisher's related data indicate that TCE-induced liver and kidney cancers most likely depend on cytotoxic mecha-method (Fisher, 1973) to combine all the study-specific results for that site. This procedure tests for each site nisms that correlate better with peak metabolite concentration than with total metabolite yield or average the global null hypothesis that there is no carcinogenic effect in any of the experiments. metabolite concentration (Appendix). Therefore, cumulative or average measures of dose are unlikely to be Epidemiological information was also considered for identification of plausible target tissues in humans. Epappropriate for these cancer end points.
Iterative, numerical methods are typically used to do idemiological studies of TCE generally have been evaluated as indicating either inadequate, negative, or lim-PBPK calculations of peak concentrations of administered chemicals or metabolites in tissue or blood (Bogen ited/inconsistent evidence of cancer causation (IARC, 1982 (IARC, , 1988 (IARC, , 1995 EPA, 1985; Bogen et al., 1988; Fan, and Hall, 1989; Bogen, 1990) . We illustrate below how an alternative, algebraic method that Bogen (1988 Bogen ( ) ap-1988 Brown et al., 1990; Weiss, 1996) . Several recent studies concluded that environmental and occupational plied to TCE, assuming a genotoxic mechanism of action, can be extended to the case in which a cytotoxic exposures to TCE have not caused cancer in humans (Fagliano et al., 1990; Mallin, 1990; Spirtas et al., 1991 ; mechanism of action (driven by peak metabolite concentrations) is assumed. This method permits simpli- Stewart et al., 1991; Axelson et al., 1994; Koivusalo et al., 1994) . The IARC (1995) reevaluation of epidemiofied estimation of safe concentrations for low-level human exposure scenarios, based on rodent cytotoxicity logical evidence as ''limited'' is based on small increases in liver and biliary-tract cancers and non-Hodgkin's data. As described below, we first selected plausible target tissues for TCE-induced cancer under an as-lymphoma in two cohort studies of exposed workers (Spirtas et al., 1991; Anttila et al., 1995) and in a third sumed cytotoxic mechanism of action. The merits of this assumption are addressed in the Appendix. We cohort study which was evaluated by its authors as negative (Axelson et al., 1994) . None of these three next assessed the plausibility of the measures we used for effective dose in target tissues by comparing PBPK studies controlled for likely confounding factors such as alcohol consumption, diet, and smoking. In the TCEestimates of these doses to corresponding bioassay data on toxicity and tumor incidence. We then applied a exposed cohort studied by Anttila et al. (1995) , involving 1698 male and 1391 female factory workers over margin of exposure of 1000 to address uncertainty in extrapolating acute cytotoxicity NOAELs in animals a 25-year period for whom biological monitoring was conducted, only cervical cancer incidence was found to to safe chronic exposure levels in humans. Cytotoxic effective doses were also estimated for occupational ex-be significantly elevated during the entire study period;
however, among workers with 20/ years since the first posure scenarios. Details of methods used for targettissue selection and for PBPK analysis are presented exposure measurement, incidence was found to be significantly elevated for several sites, including liver in under Methods. Under Results, we present our basis for target-tissue selection and assess the plausibility men and women combined (SIR Å 6.07, 95% CI Å 1.25-17.7) and in men only (SIR Å 13.0, 95% CI Å 2.68-of the effective-dose measures and MCLs we obtained for cancer end points potentially related to chronic hu-37.9). A recent retrospective cohort study found the incidence of kidney tumors to be significantly increased man TCE exposure. The Discussion and Conclusions reflect on results and regulatory implications.
(SIR Å 11.2, 95% CI Å 4.49-23.0) among workers in a German cardboard factory who experienced prolonged exposures to TCE dermally and by inhalation of high METHODS air concentrations often causing ''drowsiness and headaches' . In another study, eviCarcinogenicity data and analysis. Results of 35 long-term, chronic exposure experiments of TCE are dence for renal toxicity was not found in workers exposed chronically to Ç50 mg/m 3 TCE in air (Seldén et reported in the Carcinogenic Potency Database, including dosing by gavage or inhalation in several strains al. , 1993) . of rats and mice and in hamsters (Gold et al., 1997) .
NOAEL identification and adjustment. In the These results are summarized in Table 1 for organs PBPK analysis described below, TCE-induced cancer evaluated as a target site in at least one experiment.
in mice is assumed to be caused indirectly by cytotoxic For each target site, the P value reported for each exeffects of TCE's primary reactive metabolite, TCA (see periment indicates the statistical significance associAppendix for a discussion of data bearing on the merits ated with a test of whether the slope of a corresponding fitted one-hit dose-response model is different from 0, of this assumption). Peak blood concentrations corre- Abbreviations: (Routes) Inh, ppm in air by inhalation 7 hr/day for 5 day/week; Gav, mg/kg/day by gavage in oil 5 days/week. Studies: 1, Maltoni et al. (1986); 2, Henschler et al. (1980); 3, Fukuda et al. (1983); 4, NCI (1976); 5, NTP (1990); 6, NTP (1988) . Administered daily exposures are listed; NCI (1976) values listed for mice were applied for 66 weeks (means were 1169 and 2339 mg/kg for low-and high-dose males and 869 and 1739 mg/kg for low-and high-dose females) and for rats were applied for 62 weeks (means were 549 and 1097 mg/kg for low-and high-dose groups of either sex). All study-specific P values test the null hypothesis that the dose -response slope is 0; tests for NCI and NTP studies are based on a life-table analysis, and those for other studies are based on the summary incidence data shown (Gold et al., 1984 test was used to test the nonrandomness of sets of P values corresponding to multiple studies within each of the indicated sets of species-and site-specific studies (Fisher, 1973 f TCE carcinogenicity is also indicated by data on female B6C3F1 mice exposed to 0, 2, 6.67, and 20 mmol/liter TCA in drinking water for 82 weeks, after which liver carcinoma incidence was 0/ 40, 0/40, 0/19, and 5/20, respectively (P õ 0.05) (Pereira, 1996) . Similar results were obtained in a 1-year mouse bioassays (Herren-Freund et al., 1987; Pereira and Phelps, 1996) .
late well with oxidative-damage-mediated hepatotoxicity for chlorinated solvents such as carbon tetrachloride and chloroform (see Bogen, 1990; Larson et al., 1994) . Cytotoxic effects involving simultaneous effects on multiple targets (e.g., Ca 2/ ion pumps destroyed by oxidative stress, or S-phase induction by increased metabolic or repair demands) are likely to have thresholdlike (e.g., log-normal) dose-response relationships (Aitchison and Brown, 1957; Bogen, 1990) . We therefore used peak TCA concentration in plasma as a biological effective-dose surrogate for TCE-induced liver cancer, which we assumed to be elicited by TCA-mediated cytotoxicity produced with a threshold-like dose response.
In B6C3F 1 mice administered single doses of TCA by gavage, production of reactive substances indicating oxidative tissue damage was not elevated above control levels at 100 mg/kg body weight (BW), but was elevated at higher doses (Larson and Bull, 1992a-see Appendix) . The 100 mg/kg dose produced a measured peak concentration, Max(C TCA ), of TCA in mouse blood plasma equal to 130 mg/liter (790 mmol/liter) (Larson and Bull, 1992a) . A Max(C TCA ) value of 130 mg/liter thus represents an acute NOAEL for TCA-induced liver
FIG. 1.
Plasma concentration of TCA in B6C3F 1 mice administered TCE 5 day/week for 1 week, estimated by the PBPK model of cytotoxicity in these mice. For kidney, we assumed that Fisher et al. (1991) and Allen and Fisher (1993) , after virtual dynamic tumors are induced by TCE in rodents or humans only equilibrium is established according to this model (after 2-3 weeks at cytotoxic levels of reactive TCE-conjugation metabo-of such exposure). (a) Top and bottom curves correspond to highlites, which are hypothesized to be formed predomi-and low-dose males, respectively, exposed by gavage (NCI, 1976; see nantly or exclusively when oxidative TCE metabolism Table 1 ); (b) top, middle, and bottom curves correspond to positive studies of high-, middle-, and low-dose males, respectively, exposed is relatively saturated (Goeptar, 1995; see Appendix) .
by inhalation (Maltoni et al., 1986 ; see Table 1 ).
By convention, 10-fold safety factors have been applied to an experimental NOAEL to obtain a corresponding MCL (Dourson and Stara, 1983) . We have used three such factors to reflect: (1) uncertainty in plus one compartment representing TCA in plasma.
We first applied the model (implemented in Mathematextrapolating an acute NOAEL to chronic concentrations expected to be cytotoxic in rodents, (2) uncer-ica 2.2; Wolfram, 1991) numerically to investigate the consistency of our assumed acute mouse NOAEL for tainty in extrapolating biologically effective dose from rodents to humans, and (3) human interindividual vari-liver cytotoxicity with data for hepatocellular carcinoma incidence in B6C3F 1 mice that had been exposed ability in susceptibility to TCA-induced cytotoxicity. Note that the first factor implies an estimated NOAEL chronically to TCE 5 day/week by gavage in corn oil (NCI, 1976; NTP, 1990 ; male and female mice), TCE 7 of Max(C TCA ) Å 13 mg/liter for liver cytotoxicity in chronically exposed mice. This value is 10-to 40-fold hr/day for 5 day/week by inhalation (Maltoni et al., 1986 ; male and female mice), and TCA in drinking waless than the value of Max(C TCA ) expected in B6C3F 1 mice in which liver DNA synthesis was increased after ter (Pereira, 1996; female mice). Our C TCA calculations used PBPK parameter values that were reported pre-11 daily doses of 100 mg TCA/kg BW (Dees and Travis, 1994 ; see Appendix), based on the TCA pharmacokinet-viously (Fisher et al., 1991; Fisher and Allen, 1993) ; mouse respiratory values were additionally based on ics data of Larson and Bull (1992a) .
inverse-variance-weighted averages of the measured PBPK assessment of cytotoxic dose measures. To fraction, P 0 , of TCE metabolized to TCA, using the sexmodel effective dose for liver toxicity and cancer, we specific P 0 values reported by Fisher et al. (1991) . calculated C TCA values for mice and humans for speciFor female mice dosed daily by gavage or inhalation, fied TCE or TCA exposure scenarios using the PBPK predicted weekly C TCA patterns exhibited five daily model described and parameterized by Fisher et al. peaks followed by virtual emptying of all compartments (1991), Allen and Fisher (1993) , and Fisher and Allen by the end of the (nondosed) weekend, as noted by (1993) . This model comprises four TCE compartments Fisher and Allen (1993) . The same pattern was pre-(liver, fat, and richly and poorly perfused viscera, with dicted for rats. Such complete emptying was not predicted for male mice ( Fig. 1) , however, so care was saturable TCE metabolism assumed to occur in liver) taken to run all calculations for 2-3 weeks to ensure Malignant liver-tumor incidence data for bioassays of TCE-and TCA-exposed B6C3F 1 mice (Table 1) were attainment of dynamic equilibrium in estimated peak C TCA values. For humans, 6-7 weeks of simulated expo-used to calculate increased tumor probability, P, assuming background independence. Data from these sure were required to attain virtual dynamic equilibrium. For all exposure scenarios considered, the daily bioassays were then assigned to two groups: one (Oil gavage) group exposed to TCE in oil by gavage, and peak C TCA values occurring on the last 3 days of each simulated week at dynamic equilibrium were always the other (Nongavage) group exposed either to TCE in air or to TCA in drinking water. To facilitate comparifound to have coefficients of variation £ Ç5%. Effective liver dose, Max(C TCA ), was therefore defined for all spe-son of these groups, a lognormal dose-response model, P Å F{log 10 [Max(C TCA ) 0 m]/s} was fit to the Nongavage cies as this 3-day average value at dynamic equilibrium.
data; a similar fit was obtained to the Oil gavage data by assuming that s £ the Nongavage s value (which Max(C TCA ) values in female B6C3F 1 mice exposed by Pereira (1996) to TCA in drinking water (see Table 1 , allowed convergence using the Oil gavage data).
To model effective dose for end points of nephrotoxicfootnote f ) were calculated based on data of Larson and Bull (1992a) indicating that 20 and 100 mg TCA/kg ity and kidney cancer in rats and humans, PBPK models described and parameterized by Fisher et al. (1991) BW administered in water by gavage yields Max(C TCA ) values of 230 and 790 mmol/liter in B6C3F 1 mice, re-and Fisher and Allen (1993) were used to calculate weekly maxima for daily peak values of the ratio spectively, with first-order TCA elimination from plasma at rates §0.12 hr 01 . The mice exposed chroni-Max(B)/K m , which, when ӷ1, indicates saturation of oxidative TCE metabolism (see Table 2 ). As was done cally to TCA in drinking water initially drank Ç20% of their BW per day (Pereira, 1996) , which decreased to for mice, care was taken to use only rat and human values obtained after virtual dynamic equilibrium was Ç10% of BW by the middle of the study (M. A. Pereira, personal communication). We estimated Max(C TCA ) attained (1 week for rats, 6-7 weeks for humans). The plausibility of this ratio as a measure of effective kidvalues for mice during the first half of the study, when daily water ingestion averaged Ç15% of BW. A typical ney-cytotoxic dose was assessed by comparing calculated values to the degree of kidney toxicity observed pattern of daily water consumption was assumed to comprise a brief, equal-sized drink once per hour over in male Sprague-Dawley rats exposed to TCE by inhalation (7 hr/day, 5 day/week) (Maltoni et al., 1986 ) and a 10-hr period during a 12-hr dark cycle and an 11th drink of the same size during the light cycle (Duffy et in male F344 rats exposed to TCE by gavage in corn oil (5 day/week) (NTP, 1990) . These are the only two al ., 1990, 1991) . Max(C TCA ) was calculated as the last peak in predicted plasma concentration during the studies of TCE-exposed rats that indicate statistically significant (P õ 0.05) induction of malignant tubulardark cycle after attainment of dynamic equilibrium. Fisher and Allen (1993) pertaining to TCE and TCA in a reference 70-kg adult. Higher occupational values for Q a (10 m 3 /day) and Q (0.26Q a ) were assumed for the present study.
cell kidney tumors (see Table 1 ). The Maltoni et al. tumors were induced in hamsters. For both rats and mice, results are inconsistent across experiments, and (1986) inhalation study also has the best available NOAEL for kidney toxicity in male rats.
at each site some tests are negative. The strongest evidence for carcinogenicity is for mouse liver tumors, parSimplified approach to obtain dynamic MCLs. As ticularly in B6C3F 1 mice administered TCE by gavage. an alternative to using numerical PBPK calculations, Results for administration by inhalation are less conwe used a ''steady-state'' analytic approach to PBPK sistent across strains, and for two near-replicate tests analysis (Bogen and McKone, 1987; Bogen, 1988 ; Bo-in male B6C3F 1 mice, liver tumors were induced in one gen and Hall, 1989), applied to the Fisher-Allen PBPK test but not in the other. Evidence indicating that some model. This approach was used to calculate PBPK-liver cytotoxicity and/or mitogenesis is likely to have based MCLs, both for continuous exposure to TCE in occurred at these bioassay doses is discussed in the air and for dynamic oral and respiratory exposures to Appendix. In rats, there is evidence of carcinogenicity TCE in drinking/household water. These MCLs corre-in kidney tubules for TCE given by gavage, but not by spond to cytotoxicity-related measures of effective dose inhalation. Nearly all significant results occurred in at steady state and at dynamic equilibrium, respec-bioassays evaluated by the NTP as inadequate due to tively. Specifically, the steady-state metabolized frac-toxicity and early mortality. In every test where tumors tion, f mr , of respired TCE was estimated as were increased, cytotoxic effects in kidney were observed (see Appendix). In nearly all of the NTP rat experiments with kidney tumors, tumor decreases were
seen at other sites, with the strongest evidence for adrenal gland. The only significant increase by inhalation (in male Sprague-Dawley rats) was not considered a in which the parameters Q a , Q, P b , V max , and K m are positive result by Maltoni et al. and was not seen in a described and corresponding parameter values used for near-replicate experiment. When adjusted for the effect humans are listed in Table 2 . The corresponding of multiple tests, the overall result for malignant tusteady-state metabolized fraction of an ingested dose mors of kidney tubules is not statistically significant was estimated as (P Å 0.11, Table 1 ). Increases in benign tumors of the testis occurred in some rat strains, but not in others.
(2) Malignant tumors of the mouse lung were significantly increased (P Å 0.017) in only 1 of 12 experiments, and the only significant result for combined malignant and An analytic approach was also taken for exposure benign lung tumors was in a different experiment (P Å scenarios involving repeated, relatively brief daily infu-0.001, Table 1 ). When adjusted for the effect of multiple sions into a first-order system, resulting in multiple tests, neither malignant nor combined benign and madosing kinetics characterized by a ''sawtooth'' approach lignant lung tumors were significantly increased (P ú to dynamic-equilibrium oscillation between a maxi-0.05, Table 1 ). mum and relative minimum values (see, e.g., Wiegand
Epidemiological evidence concerning possible carcinet al., 1963) . Thus, after a sufficiently lengthy regime ogenic effects of TCE in humans (see Methods) is generof such multiple dosing, peak concentrations at virtual ally considered inadequate, negative, or limited/incondynamic-equilibrium all equal a fraction, sistent, but includes some data that (albeit inconclusively) suggest a positive effect for cancer in tissues that are clearly positive in rodent bioassays. This anal-
ysis of rodent bioassay results and the human evidence supports the selection of liver and kidney as target sites to illustrate our proposed simplified PBPK method of of the steady-state concentration that would be deriving MCLs designed to protect exposed humans. achieved if system input were continuous, where t is the assumed daily infusion duration, t p is the exposure/ Consistency of dose metrics with data on liver and nonexposure cycle period (t p Å 24 hr), and k is the firstkidney end points. For seven B6C3F 1 mouse bioasorder rate constant governing loss (in this case, of TCA says, Fig. 2 plots the normalized increased probability from plasma).
of hepatocellular carcinoma incidence as a function of estimated effective dose, Max(C TCA ). All rates of sig-
RESULTS
nificantly increased liver cancer correspond to Max(C-TCA ) values ú130 mg/liter, the NOAEL identified by Target tissues for carcinogenesis. The bioassay re- Larson and Bull (1992a) for acute liver cytotoxicity. sults and data analysis summarized in Table 1 indicate The lowest such value, 153 mg/liter, is for dosed males clear evidence that TCE induces tumors in some rodent tissues. Target sites differ in rats and mice, and no in the NTP (1990) gavage study. Figure 2 also shows posed workers reported by Axelson et al. [1994] [1995] to have had increased liver/biliary-tract cancer incidence).
Simplified MCL calculation. The PBPK model used implies that the blood concentration, C TCA (t), of TCA in humans at time t changes at the rate corresponding values used by Allen and Fisher (1993) plasma concentration of TCA, calculated for female and male B6C3F 1 are listed in Table 2 . Substituting the appropriate valmice chronically exposed to TCE or TCA for Ç2 years. Mice were ues, Eq. (4) may be rewritten exposed to TCE in oil 5 day/week by gavage (NCI, 1976; NTP, 1990) , to TCE by inhalation 7 hr/day and 5 day/week (positive studies by Maltoni et al., 1986) , and to TCA in drinking water (Pereira, 1996) Table 1 ). Error bars denote {1 SD assuming binomial sampling error. A lognormal fit (solid curve) is shown for the nongavage data involving respiratory and drinking-water exposures; a corresponding 0 0.00783 hr 01 C TCA (t), (5) fit (dashed curve) is shown for the data involving exposure to TCE in oil by gavage.
here the parenthesized quantity in Eqs. (4) and (5) is simply the rate of TCE metabolism at time t conditional on B(t). After continuous respiratory exposure to a lognormal fits to Oil gavage and Nongavage data. Pagiven TCE concentration (C in ) in air, B(t) eventually rameter estimates obtained for the Nongavage data attains a steady-state value B(ϱ) that corresponds to a were m Å 710 mg/liter and s Å 0.22; for the Oil gavage rate of TCE metabolism equal to Q a C in f mr , where f mr Å data, the corresponding estimates were m Å 220 mg/ 0.671 (using Eq. (1) under Methods and the reference liter and s Å 0.22.
Q a value listed in Table 2 ). The steady-state solution For kidney end points, Table 3 lists PBPK-based estito Eq. (5) for small C in (such that B(ϱ) Ӷ K m ) is therefore mates of toxicity-related effective dose in male rats exposed chronically to TCE by inhalation (Maltoni et al., C TCA (ϱ) Å 7.38 hr liter 01 Q a C in f mr 1986) and by gavage (NTP, 1990) . The values of the TCE-metabolism saturation index, Max(B)/K m , for rats Å 1450 C in . (6) shown in this table are substantially ú1 for all exposed groups, and kidney toxicity was observed in all but one
We obtained a corresponding MCL for cytotoxicityof these groups (the rats exposed to the lowest TCE induced liver cancer by substituting the NOAEL TCA concentration by inhalation). The corresponding calcu-concentration of 130 mg/liter for C TCA (ϱ) Å Max(C TCA ) lated values of effective liver dose listed in Table 3 for in Eq. (6) and dividing this concentration by a 1000-rats (in which liver is not a TCE-related target site) fold safety factor. The MCL thus obtained is Ç0.090 are all substantially below 130 mg/liter, the NOAEL mg/liter (16 ppb) for TCE in continuously respired air. for acute liver toxicity in B6C3F 1 mice discussed above. At this air concentration, it is easily shown analytically (Bogen, 1988) 
that in this case B(ϱ) õ 10
04 K m , which Prediction of occupational hazard. Table 3 also refers to various human occupational (8 hr/day, 5 day/ satisfies the B(ϱ) Ӷ K m constraint.
For TCE-contaminated air that is inhaled for some week) scenarios involving time-weighted average respiratory exposures to £100 ppm TCE, which is the OSHA relatively brief period t, the right-hand side of Eq. (6) must be multiplied by the fraction f deq defined in Eq. (1993) permissible exposure limit (PEL). All the scenarios correspond to a calculated effective kidney dose £ (3) (see Methods and Table 1 ). For example, t Å 0.50 hr might be assumed to reflect daily shower/bathroom Ç1, indicating that TCE metabolism is not expected to be saturated in humans exposed to these levels. In use, in which case the corresponding value, f deq Å 0.0228, and a 1000-fold safety factor implies a 44-fold contrast, the corresponding values shown for effective liver dose, Max(C TCA ), are all greater than the 130 mg/ larger respiratory MCL (Ç700 ppb) for that daily exposure period, assuming other household air concentraliter acute NOAEL in mice (i.e., without safety factors), except that for the smallest TCE concentration consid-tions are negligible.
Similarly, Eq. (5) implies that small daily bolus TCE ered (20 ppm-the mean exposure of 1670 TCE-ex- Table 2 ) are those reported by Fisher et al. (1991) for the rat (scaled as in that study for the weights indicated) and by Fisher and Allen (1993) .
b
Exposure scenarios refer to lifetime bioassays by inhalation (7 hr/day, 5 day/week) and by gavage in corn oil (5 day/week) and the following occupational (8 hr/day, 5 day/week) scenarios: 20 ppm, mean exposure of 1670 TCE-exposed workers studied by Axelson et al. (1994) ; 50 ppm; ACGIH's ''TLV'' allowed time-weighted average (TWA) exposure (ACGIH, 1993) ; 100 ppm, OSHA's allowed TWA exposure, and 4 1 (0 ppm for 62.5 min, 200 ppm for 52.5 min, 300 ppm for 5 min) is an OSHA-allowed daily pattern of maximal exposure pulses (OSHA, 1993) . ingestions, each resulting in an approximately con-Nongavage data in Fig. 2 (inhalation, squares; drinking water, diamond) are described approximately by a relastant infusion of M (mg) over time t (hr), corresponds to a steady-state TCA concentration in blood of tively gradually inclining continuum of carcinoma probability vs Max (C TCA ) Figure 2 also indicates that if Max(C TCA ) is and (2) (Methods). Fisher and Allen (1993) assumed indeed a meaningful common measure of dose for liver that human gastrointestinal TCE absorption was a toxicity and cancer, there is variability in susceptibility first-order process with a rate constant of 5.5 hr 01 , by sex within both the Oil gavage and the Nongavage which corresponds to a gastrointestinal uptake half-groups of B6C3F 1 bioassay mice. Nevertheless, this time of 7.56 min. However, for t £ 2 hr, the fraction figure appears to indicate a distinction between the Oil (f deq /t) in Eq. (7) is relatively insensitive to different gavage and the Nongavage groups beyond any differvalues of t, remaining approximately 0.0455 hr 01 . ences in sex-specific susceptibility. Therefore, Eq. (7) implies that Ç427 g TCE must be
The relatively greater risk per unit effective dose ingested per day to achieve a peak TCA concentration among oil-gavage B6C3F 1 mice is consistent with the in blood-again using a 1000-fold safety factor-equal observed enhancement of liver toxicity and carcinogeto 0.130 mg/liter at dynamic equilibrium, assuming nicity of chloroform when administered by oil gavage Ç100% absorption within 2 hr. This intake corresponds rather than via drinking water (Jorgenson et al., 1985;  to an MCL of approximately 210 ppb for TCE in drink- Larson et al., 1994) . Such apparent enhancement of the ing water ingested at 2 liter/day. Again, it is easily ''potency'' of our calculated Max(C TCA ) values resulting shown analytically that B(ϱ) É 10 03 K m in this case (see from TCE administered in oil, as opposed to water, may Bogen, 1988) , which satisfies the B(ϱ) Ӷ K m constraint. be due to a lack of realism in the PBPK model we used.
The MCLs obtained for TCE in water and air address According to this model, TCE is transferred to liver liver cancer assuming a cytotoxic mechanism of action. and kidney by blood perfusion upon its partition into Because these MCLs both satisfy a B(ϱ) Ӷ K m con-blood, without accounting for higher TCE concentrastraint (by a factor of Ç10 3 or more), the corresponding tions expected in blood-borne oil droplets delivered to values of the ratio Max(B)/K m are similarly Ӷ1. The metabolizing and/or target hepatocytes after adminisMCLs therefore also apply to kidney cancer under our tration of TCE by oil gavage. (Note that a fat:blood assumption that this end point results from cytotoxic-partition coefficient of Ç30-40 was used in the model ity caused by reactive metabolites produced when TCE for TCE in mice.) The Max(C TCA ) values we calculated metabolism is relatively saturated.
for Oil gavage bioassay mice might thus underestimate those corresponding to TCA concentrations that actu-DISCUSSION ally arose in target hepatocytes after exposure. If so, a more refined analysis might predict larger Max(C TCA ) values for Oil gavage mice, such that the dashed curve Our results indicate the general consistency of our calculated measures of effective dose with observed shown in Fig. 2 would be closer to the solid curve corresponding to Nongavage data. Other explanations of the patterns of cytotoxicity and tumor induction in mice and rats. The comparison of calculated effective kidney discrepancy between the Oil gavage and the Nongavage are possible. Resolution of this question would be doses vs kidney toxicity incidence in rats (Table 3) shows that the measure of effective kidney dose used, facilitated by data comparing TCA and TCE concentrations in liver under different TCE-exposure conditions. Max(B)/K m , is consistent with relevant rat toxicity data. Effective liver doses we calculated are likewise Liver cytotoxicity was not observed to be elevated in mice given an acute dose of 100 mg dichloroacetic acid consistent with data on increased liver-cancer rates observed in B6C3F 1 bioassay mice (Fig. 2) , insofar as our (DCA)/kg BW (Larson and Bull, 1992a) , whereas hepatocellular toxicity and increased liver cancer were obpredicted NOAEL of Max(C TCA ) Å 13 mg/liter for chronic hepatocellular toxicity in mice falls well below served in male B6C3F 1 mice exposed for 104 weeks via drinking water to Ç93 mg DCA/kg day (Daniel et al. , all calculated effective liver doses at which significantly increased incidence has been observed for liver cancer 1992). Thus, chronic DCA exposure is apparently more hepatotoxic than an acute DCA dose. Such a difference (as well as induced DNA synthesis indicative of mitogenesis-see Appendix). However, Fig. 2 shows a clear might also be expected for TCA, although TCA is somewhat less hepatotoxic than DCA (see Appendix). difference between data from studies involving exposure by gavage to TCE in oil (NCI, 1976; NTP, 1990) The results discussed here may have important implications concerning how best to manage any risk vs exposure either to TCE by inhalation (Maltoni et al., 1986) or to TCA via drinking water (Pereira, 1996) . The posed by TCE exposures. If our assumption of cytotoxic mechanisms for potential carcinogenic action of TCE ety of experimental evidence (see Appendix). Our proposed method used with a 1000-fold margin of exposure in humans is correct, then the U.S. EPA and California MCLs of 5 ppb for TCE in water (United States, 1996; yielded MCLs for TCE of 16 ppb (87 mg/m 3 ) for TCE in air respired 24 hr/day, 700 ppb (3.8 mg/m 3 ) for TCE in CDHS, 1994) may be overly stringent by a factor of Ç40. This possibility pertains not only to purely in-air respired for relatively brief daily periods (e.g., 0.5 hr while showering/bathing), and 210 mg/liter for TCE gestive exposure, but also to realistic multiroute exposure to TCE from household water, because TCE con-in drinking water assuming a daily 2-liter ingestion.
Cytotoxic effective doses were also estimated for occentrations in shower and bathroom air are only Ç2 and 0.4%, respectively, of those in household water cupational respiratory exposures. These estimates indicate that the current OSHA PEL for TCE would pro- (McKone, 1987; Andelman, 1990) . In contrast, cytotoxic effective doses predicted for occupational respiratory duce metabolite concentrations that exceed an acute no observed adverse effect level for hepatotoxicity in mice exposure scenarios (Table 3 ) indicate that the current OSHA (1994) PEL for TCE corresponds to a TCA con-without any safety factors. On this basis, the OSHA PEL for TCE is not expected to be protective. centration that exceeds an acute NOAEL for TCA-induced hepatotoxicity in mice. This analysis supports the earlier conclusion of Gold et al. (1994) , based on APPENDIX: CYTOTOXICITY AND direct comparison of administered tumorigenic doses
TCE-INDUCED CANCER
in rodents (in mg/kg/day) to permitted respiratory exposures in the workplace (in mg/kg/day), that OSHA TCE is relatively unreactive, but is metabolized to a PELs may fail to protect workers from risks posed by reactive epoxide which is decomposed in microsomes to carcinogenic chemicals. chloral hydrate (CH) and in cytosol to DCA, N-(hydroxyacetyl)aminoethanol, glyoxylic acid, formic acid,
CONCLUSIONS
and/or carbon monoxide; CH in turn is oxidatively metabolized in rodents and humans principally to the mePrevious PBPK-based estimates of human cancer tabolites TCA and trichloroethanol, of which TCA has risk from TCE have relied on cumulative or average the longest half-life in circulated blood (Dekant et al., measures of dose, based on the hypothesis that TCE 1984 TCE , 1986a EPA, 1985 ; Rouisse and Chakrabarti, induces cancer by virtue of its ability to cause DNA 1986; Davidson and Beliles, 1991; Larson and Bull; damage. Cancer risk assessments for TCE based on 1992a; Templin et al., 1993) . The metabolites are then linear extrapolation from bioassay results are question-subject to further spontaneous degradation, enzymeable in light of data indicating a more likely cytotoxic mediated oxidative and/or reductive metabolism, and/ mechanism of action, which has spurred regulatory in-or glutathione or glucuranide conjugation (Davidson terest in methods to define safe TCE exposures under and Beliles, 1991; 1992a;  Templin et this alternative mechanistic assumption (EPA, 1996 (EPA, ). al., 1993 . In rodents and humans, TCA partitions to We have shown here how the algebraic PBPK method extracellular water and is tightly and extensively applied by Bogen (1988) to TCE under a genotoxic-bound to plasma protein. Roughly 50-80% of metabomechanism assumption can be extended to the case in lized TCE is excreted in urine as TCA and as free plus which TCE is assumed to induce cancer via cytotoxic glucuranide-conjugated trichloroethanol (Bogen et al., mechanisms that correlate better with peak metabolite 1988; Davidson and Beliles, 1991) . In both rats and concentration than with total metabolite yield or aver-mice, TCA is metabolized (probably oxidatively) to DCA age metabolite concentration. The methods allow a (Larson and Bull, 1992a ), which appears as a relatively simplified, algebraic estimation of environmentally small percentage (1-2%) of urinary metabolites (Hasafe concentrations based on PBPK-based extrapola-thaway, 1980; Dekant et al., 1984;  Green and Prout, tion from rodent toxicity data, instead of iterative nu-1985; Larson and Bull, 1992a) . In TCE-exposed humerical computation methods typically applied when mans, DCA has not been measured as a urinary or peak concentrations are used as measures of biologi-other metabolite (Hathaway, 1980; Dekant et al., 1984; cally effective dose. Green and Prout, 1985) ; only Ç5% of TCE epoxide Based on a new analysis of rodent-bioassay data, as formed is degraded to either DCA or other non-CHwell as a review of human data indicating little defini-metabolites . tive additional information, we conclude that liver and kidney are appropriate target tissues for assessing risk Liver cancer. In mice, TCE-induced cytotoxicity occurs primarily in liver, the principal site of TCE metabof TCE-induced cancer. When applied to malignant tumor-incidence and acute-toxicity data, our measures of olism. Liver toxicity in mice correlates with the total amount of TCE metabolized, indicating that major PBPK-based cytotoxic effective dose were found to be consistent with the assumption that increased tumor forms of TCE-induced chronic cytotoxicity are almost certainly caused by TCE metabolism or metabolites incidence is unlikely to occur in the absence of chronic cytotoxicity-an assumption also supported by a vari-rather than by TCE itself (Buben and O'Flaherty, 1985; Prout et al., 1985; EPA, 1985 EPA, , 1987 ; Rouisse and Chak-those for mice, except that 300 mg TCA/kg failed to elevate TBARS in rats Bull, 1992a). rabarti, 1986; Davidson and Beliles, 1991) . Liver and kidney weights were significantly increased, and liver-DCA is a minor urinary TCE metabolite in rats (in which TCE is not hepatocarcinogenic) and mice (in related serum enzyme levels were significantly perturbed, in different strains of mice (including B6C3F 1 ) which TCE is hepatocarcinogenic). In male B6C3F 1 mice administered approximately 2000 mg (15 mmol) exposed chronically to TCE by inhalation or by cornoil gavage (Kjellstrand et al., 1982 (Kjellstrand et al., , 1983a  Buben and TCE/kg BW in 1-2% aqueous Tween 80, the measured area under the blood concentration vs time curve for O 'Flaherty, 1985) . These toxic effects were observed at doses lower than those administered in positive cancer DCA was approximately 30-fold smaller than that for TCA (Larson and Bull, 1992b; Templin et al., 1993) . bioassays (Table 1) . However, in male Swiss-Cox mice dosed with TCE in corn oil 5 day/week for 6 weeks by Templin et al. (1993) concluded that DCA and TCA production kinetics were consistent with the hypothegavage, elevated serum SGPT levels were observed at daily doses of 1600-3200, but not at 200-800 mg TCE/ sis that TCE-induced mouse-liver cancers may be caused by either DCA or TCA or by both. However, kg BW, which was considered evidence of a threshold for induction of liver cytotoxicity (Buben and O'Fla-substantially increased DCA levels did not arise from TCE doses increasing from 100 to 2000 mg/kg in mice herty, 1985; Bruckner et al., 1989) . All male and female B6C3F 1 mice given 100, 250, 500, or 1000 mg TCE/kg (Templin et al., 1993) , in contrast to the increase in mouse liver cancer observed over this dose range (Table  BW in corn oil by gavage for 10 days were observed to be clinically ill and show some liver histopathology 1, Fig. 2) . Thus, DCA does not easily explain a substantial fraction of mouse-liver cancers induced by TCE, (Dees and Travis, 1993) . While reports of TCE-induced liver cancer in bioassays (NCI, 1976; NTP, 1988 NTP, , 1990 ; and TCA is a more likely explanation.
Several mechanisms have been suggested to explain Maltoni et al., 1986) do not implicate frank hepatocellular toxicity (Table 1) , these studies included neither why TCE-induced cytotoxic effects in liver, such as cell division increased by peroxisome proliferation, may be blood-chemistry data nor detailed examinations of mild or subtle cytotoxicity; furthermore, if a tumor was pres-fundamentally related to pharmacodynamics of TCE hepatocarcinogenicity in mice. Substantial peroxisome ent, toxic lesions were often not recorded (J. Ward, U.S. National Toxicology Program, personal communica-proliferation is observed in mice, but the effect is weaker in rats, after administration of TCE by gavage tion).
Major TCE metabolites (chloral hydrate, TCA, and in corn oil for 10 days; this has been considered evidence that differential peroxisome proliferation may DCA) all induce liver cancer in mice when administered in buffered drinking water (Herren-Freund et al., explain differences in TCE-induced hepatocarcinogenicity in mice vs rats Elcombe et al., 1987; Bull et al., 1990; DeAngelo and Daniel, 1990; DeAngelo et al., 1991; Daniel et al., 1992, Pereira and McClain, 1994) . These observations also have been used to support the hypothesis that TCE is Phelps, 1996; Pereira, 1996) . TCE is hepatocarcinogenic in mice but not rats, which is consistent with the unlikely to induce liver cancer in humans, because monkey and human hepatocytes are much less suscephigher peak-plasma concentrations of TCA and DCA measured for B6C3F 1 mice administered TCE in drink-tible to induction of peroxisome proliferation than rodent hepatocytes Eacho et al., 1986 ; ing water than those measured for similarly exposed F344 rats (Larson and Bull, 1992b) . In mice, strain McClain, 1994) .
Multistage theories of carcinogenesis imply that differences in metabolism are also noteworthy. TCA accounts for 7-12% of an oral TCE dose in B6C3F 1 and dose-related changes in cell-proliferation kinetics may alter tumor risk, without direct involvement of genoSwiss mice, but is only a trace urinary metabolite in NMRI mice (Dekant, 1986b) . Liver and lung tumors toxicity (Armitage and Doll, 1957; Moolgavkar and Knudson, 1981; Moolgavkar, 1983; Moolgavkar et al. , were induced in TCE-exposed B6C3F 1 and Swiss mice, but not in NMRI mice (Table 1) . TCA and DCA are 1988; Bogen, 1989; Ames and Gold, 1990; Cohen and Ellwein, 1990, 1991; Preston-Martin, 1990 ; Monticello clearly hepatotoxic in mice at chronic tumorigenic oral doses and somewhat less hepatotoxic in rats when ad-and Morgan, 1994). For chemicals such as chlorinated solvents that injure liver cells through oxidative stress, ministered in drinking water (Bull et al., 1990; Mather et al., 1990) . After single oral doses of NaOH-buffered dose-response data for tumors and related cytotoxicity are substantially nonlinear or threshold-like, in accor-TCA or DCA (or CCl 4 , as a positive control) in water, elevated TBARS (thiobarbituric acid-reactive sub-dance with cell-kinetic multistage analyses presuming a cytotoxic mechanism of action (Bogen, 1990 ; Larson stances indicative of lipoperoxidative-stress-induced cell killing in liver, similar to that induced by CCl 4 ) et al., 1994; Smith et al., 1995) . Acute and subchronic TCE administration in corn oil by gavage has been were observed in B6C3F 1 mice given 300, 1000, and 2000 (but not 100) mg TCA/kg BW, and in mice given shown to significantly increase S-phase DNA synthesis and proliferation in mouse hepatocytes (Mirsalis et al., 300 and 1000 (but not 100) mg DCA/kg (Larson and Bull, 1992a) . Results for F344 rats were similar to 1985, 1989; Dees and Travis, 1993, 1994) . Dees and Travis (1993, 1994 ) assessed hepatotoxicity in male
The S-dichlorovinyl-L-cysteine (DCVC) TCE conjugates S-(1,2-dichlorovinyl)-L-cysteine (1,2-DCVC) and and female B6C3F 1 mice given 0, 100, 250, 500, and 1000 mg TCE/kg BW in corn oil by gavage for 10 days S-(2,2-dichlorovinyl)-L-cysteine, the corresponding mercapturic acids (DCV-Nac) formed by DCVC N-acetylaand 100 mCi/kg [ 3 H]thymidine 6 hr prior to sacrifice. Not only did all treated mice appear clinically ill and tion N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine and Nacetyl-S-(2,2-dichlorovinyl)-L-cysteine, and the glutaexhibit liver histopathology (as noted above), but radiolabeled hepatocytes were also significantly increased thione TCE conjugate S- (1,2-dichlorovinyl) glutathione (transformed to DCVC by g-glutamyl transferase as in all treated groups. In a parallel mouse study using 100-1000 mg TCA/kg BW in corn oil by gavage for well as peptidase enzymes) are all rodent (and possible human) TCE metabolites that can produce proximal 11 days, all treated groups appeared healthy but had significantly elevated liver weights and hepatocellular tubular necrosis and other (e.g., proliferative) nephrotoxic lesions in rat (and possibly human) kidney after [ 3 H]thymidine levels (Dees and Travis, 1994) . In B6C3F 1 mice exposed to either TCA (at 2, 6.67, and 20 conversion to reactive, mutagenic intermediates by (primarily cytosolic) cysteine conjugate b-lyase (Elmmol/liter) or DCA (at 6.67 or 20 mmol/liter) administered in drinking water, hepatocellular DNA-labeling farra et al., 1984 DNA-labeling farra et al., , 1986a Dekant et al., 1986b Dekant et al., ,c, 1989 Vamvakas et al., 1988; Commandeur et al., 1991 ; Walindex (indicating increased cell proliferation) was observed to be significantly elevated after 5 days of expo-lin et al., 1992; Goeptar et al., 1995) . In the absence of b-lyase activity, rat kidney cells are almost completely sure, but not after 12 or 33 days of exposure (Pereira, 1996) . Ferreira-Gonzalez et al. (1995) showed that he-protected against 1,2-DCVC-induced cytotoxicity (Elfarra et al., 1986a; Stephens et al., 1986) . Exposure of patocellular carcinomas induced by chronic lifetime exposure to DCA (at 1 or 3.5 g/liter) or TCA (at 4.5 g/ cultured rat kidney cells to 1,2-DCVC has also been shown to induce c-fos and c-myc protooncogene expresliter) in drinking water have a ras oncogene mutation frequency and (in the case of TCA) spectrum approxi-sion to levels that are also induced by growth factor (fetal calf serum) or by the tumor promoter, 12-O-tetramately equal to those seen in spontaneous tumors, indicating that TCE metabolites probably accelerate decanoylphorbolacetate (Vamvakas and Köster, 1993) .
This indicates the possibility that this TCE metabolite growth of spontaneous tumors via cytotoxic mechanisms, rather than create new malignant cells via geno-may be directly mitogenic to kidney cells, and thus promote kidney neoplasia. It is not currently known toxic mechanisms.
Based on data like those summarized above, risk as-which toxic b-lyase metabolites are most responsible for induced cytotoxicity, gene expression, and likely sessments for TCE based on linear-type risk extrapolations from bioassay liver-tumor data are increasingly mutagenicity in kidney cells exposed to TCE conjugates (Goeptar et al., 1995) . It is known that TCE-conjugation considered implausible (Abelson, 1993; Steinberg and DeSesso, 1993) . Steinberg (1993) made a similar point metabolites, such as DCV-Nac via the mercapturic acid pathway, are trace TCE metabolites formed in rodents regarding CH, the primary TCE metabolite that is also carcinogenic and also metabolized to TCA and DCA. (Commandeur and Vermeulen, 1990; Dekant et al., 1986a Dekant et al., ,b, 1990 and possibly also in humans (Birner et Noting that CH is a widely used sedative in both adults and children, Steinberg (1993) argued that a threshold al. , 1993) . Approximately 3-4 mmol/liter DCV-Nac model is appropriate for evaluation of cancer risks was measured in urine obtained 16 hr postexposure posed by medical uses of CH in humans because the from workers exposed to ''varying amounts'' of TCE rodent-cancer bioassay dose-response relationships ''during an 8-hr work shift when cleaning metal parts'' for CH and its breakdown products TCA and DCA are in a TCE bath, which concentrations were roughly 40% nonlinear, and because these bioassays all involved of those found in rat and Ç30-100% of those found in high, necrogenic doses which appear to be necessary mouse urine 22 hr after oral gavage exposure to 50 mg/ for tumor induction.
kg TCE (Birner et al., 1993) . However, occurrence of TCE-induced rat-kidney tumors is considered unlikely Kidney cancer. Different molecular mechanisms in the absence of severe chronic kidney damage, like have been hypothesized to explain TCE-induced kidney that produced when amounts of TCE conjugation with cancer in male rats (Table 1 and NCI, 1976; NTP, 1988, cysteine and glutathione become significant upon satu-1990) and an apparent cluster of renal-cell tumors in ration of the oxidative cytochrome P 450 pathway for highly exposed German factory workers (Henschler et TCE metabolism-as occurs in rats, but not mice, that al., 1995). In rats, renal cytotoxicity is central to one are highly exposed to TCE (Goeptar et al., 1995) . set of hypotheses. Most rats chronically exposed to TCE in NCI and NTP bioassays involving F344 and other rat strains developed toxic nephrosis and §90% of rats ACKNOWLEDGMENTS (and mice) developed cytomegaly, which generally was most pronounced in male rats; however, kidney tumors
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